A TV advertisement for Nurofen has been banned by the UK’s Advertising Standards Authority for providing misleading information about the drug’s painkilling effects. A separate ruling in Australia also saw the manufacturer of Nurofen, Reckitt Benckiser, fined £A$6m, in relation to misleading claims that the drug could target specific forms of pain such as migraines or backaches. The ruling is expected to have wide-reaching implications for drug companies on the way they promote general painkillers.
A TV advertisement for Nurofen has been banned by the UK’s Advertising Standards Authority for providing misleading information about the drug’s painkilling effects. A separate ruling in Australia also saw the manufacturer of Nurofen, Reckitt Benckiser, fined £940k, in relation to misleading claims that the drug could target specific forms of pain such as migraines or backaches. The ruling is expected to have wide-reaching implications for drug companies on the way they promote general painkillers.